PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 6 days 12 hours 42 minutes
Relieving the Burden of Acne and Scarring: A Holistic Approach
Relieving the Burden of Acne and Scarring: A Holistic Approach
ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels
ASCVD: Reducing the Struggle of Keeping LDL-C at Recommended Levels
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
Expanding Treatment Options in MET Exon 14-Skipping NSCLC: Clinical Insights From 2021 Virtual Congresses
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Raising the Bar in Heart Failure Management: 2021 Congress Updates on SGLT2 Inhibitors
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
Evaluating the Evidence for SGLT2 Inhibition in CKD: Highlights From the 2021 Virtual ERA-EDTA Congress
A Case in Point: Navigating the Differential Diagnosis of aHUS in Clinical Practice
A Case in Point: Navigating the Differential Diagnosis of aHUS in Clinical Practice
Identifying Bowel Urgency in Patients With Ulcerative Colitis: The Need for Speed
Identifying Bowel Urgency in Patients With Ulcerative Colitis: The Need for Speed
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?
Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?